SCHEMBL4491205

SCHEMBL4491205

O=C(Nc1ccc(OCCCN2CC3CCCC3C2)cc1)c1ccc2ccccc2c1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 1/20 0.60
NPC1 O15118 4/20 0.51
RAB9A P51151 4/20 0.51
CASP3 P42574 1/20 0.51
SENP7 Q9BQF6 1/20 0.51
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
POLB P06746 1/20 0.50
MAPT P10636 1/20 0.50
MCL1 Q07820 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
MCHR1 Q99705 4/20 0.49
DGAT1 O75907 1/20 0.48
ENPP3 O14638 2/20 0.48
ENPP1 P22413 2/20 0.48
ENPP2 Q13822 2/20 0.48
DEGS1 O15121 1/20 0.48
KDR P35968 3/20 0.48
NR1H4 Q96RI1 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4489261 0.89 HRH3 (0.66) HRH3NPC1RAB9AKMT2AMEN1
SCHEMBL4486970 0.85 HRH3 (0.64) HRH3KMT2AMEN1MAPT
SCHEMBL4492003 0.85 HRH3 (0.64) HRH3KMT2AMEN1MAPT
SCHEMBL4619491 0.85 HRH3 (0.64) HRH3NPC1RAB9AKMT2AMEN1
SCHEMBL4505078 0.83 HRH3 (0.61) HRH3
SCHEMBL4505374 0.82 HRH3 (0.60) HRH3RAB9AKMT2AMAPTSMN1; SMN2
Oxalic Acid SCHEMBL4491824 0.82 HRH3 (0.60) HRH3NPC1RAB9AKMT2AMEN1
SCHEMBL4622361 0.81 HRH3 (0.59) HRH3NPC1RAB9AKMT2AMEN1
Oxalic Acid SCHEMBL5449181 0.81 MEN1 (0.54) HRH3NPC1RAB9AKMT2AMEN1
SCHEMBL4495320 0.81 HRH3 (0.55) HRH3NPC1RAB9AKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7576120-B2 Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2009-08-18 US disclosed
US-20070197625-A1 Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them. LES LABORATORATIES SERVIER (FR) 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197625-A1 Azabicyclic compounds, a process for their preparation and pharmaceutical compositions containing them. HRH2, HNMT, HRH1 HRH3 9/4885NPC1 2317/4885RAB9A 1779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.